Tags

Type your tag names separated by a space and hit enter

Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
Ren Fail. 2008; 30(2):181-6.RF

Abstract

The estimation of the glomerular filtration rate (GFR) is an essential part of the evaluation of patients with chronic kidney disease (CKD). Recently, serum cystatin C has been proposed as a new endogenous marker of GFR. Authors compared serum creatinine, creatinine clearance calculated from Cockcroft and Gault formula and serum cystatin C against (51)CrEDTA clearance in 252 patients with CKD and GFR <90 mL/min/1.73 m(2). Analysis of correlations and diagnostic accuracy (receiver operating characteristic curves) of different GFR markers indicate that serum cystatin C is a more reliable marker of GFR in patients with CKD than serum creatinine.

Authors+Show Affiliations

Clinic for Internal Medicine, Department of Nephrology, University Medical Center Maribor, Maribor, Slovenia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18300118

Citation

Hojs, Radovan, et al. "Serum Cystatin C as an Endogenous Marker of Renal Function in Patients With Chronic Kidney Disease." Renal Failure, vol. 30, no. 2, 2008, pp. 181-6.
Hojs R, Bevc S, Ekart R, et al. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Ren Fail. 2008;30(2):181-6.
Hojs, R., Bevc, S., Ekart, R., Gorenjak, M., & Puklavec, L. (2008). Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Renal Failure, 30(2), 181-6. https://doi.org/10.1080/08860220701810315
Hojs R, et al. Serum Cystatin C as an Endogenous Marker of Renal Function in Patients With Chronic Kidney Disease. Ren Fail. 2008;30(2):181-6. PubMed PMID: 18300118.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. AU - Hojs,Radovan, AU - Bevc,Sebastjan, AU - Ekart,Robert, AU - Gorenjak,Maksimiljan, AU - Puklavec,Ludvik, PY - 2008/2/27/pubmed PY - 2008/5/14/medline PY - 2008/2/27/entrez SP - 181 EP - 6 JF - Renal failure JO - Ren Fail VL - 30 IS - 2 N2 - The estimation of the glomerular filtration rate (GFR) is an essential part of the evaluation of patients with chronic kidney disease (CKD). Recently, serum cystatin C has been proposed as a new endogenous marker of GFR. Authors compared serum creatinine, creatinine clearance calculated from Cockcroft and Gault formula and serum cystatin C against (51)CrEDTA clearance in 252 patients with CKD and GFR <90 mL/min/1.73 m(2). Analysis of correlations and diagnostic accuracy (receiver operating characteristic curves) of different GFR markers indicate that serum cystatin C is a more reliable marker of GFR in patients with CKD than serum creatinine. SN - 1525-6049 UR - https://www.unboundmedicine.com/medline/citation/18300118/Serum_cystatin_C_as_an_endogenous_marker_of_renal_function_in_patients_with_chronic_kidney_disease_ L2 - https://www.tandfonline.com/doi/full/10.1080/08860220701810315 DB - PRIME DP - Unbound Medicine ER -